Free Trial

Short Interest in Nihon Kohden Corporation (OTCMKTS:NHNKY) Decreases By 52.9%

Nihon Kohden logo with Medical background

Key Points

  • Nihon Kohden Corporation experienced a significant decline in short interest, dropping by 52.9% to 3,200 shares in July.
  • The company reported a net margin of 5.77% and earnings of $0.01 per share for the latest quarter, with revenues of $346.24 million.
  • Nihon Kohden's share price fell 6.6% to $11.18, and its market capitalization now stands at $1.91 billion.
  • Five stocks to consider instead of Nihon Kohden.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) saw a large decline in short interest in the month of July. As of July 31st, there was short interest totaling 3,200 shares, adeclineof52.9% from the July 15th total of 6,800 shares. Approximately0.0% of the shares of the company are sold short. Based on an average trading volume of 8,900 shares, the days-to-cover ratio is currently 0.4 days. Based on an average trading volume of 8,900 shares, the days-to-cover ratio is currently 0.4 days. Approximately0.0% of the shares of the company are sold short.

Nihon Kohden Stock Up 6.2%

NHNKY stock traded up $0.67 during midday trading on Friday, hitting $11.54. The company's stock had a trading volume of 4,777 shares, compared to its average volume of 5,509. The firm has a market capitalization of $1.97 billion, a price-to-earnings ratio of 21.37 and a beta of 0.34. Nihon Kohden has a 12 month low of $9.86 and a 12 month high of $17.28. The company has a 50 day moving average of $11.98 and a two-hundred day moving average of $12.91.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.01 earnings per share (EPS) for the quarter. The company had revenue of $346.24 million during the quarter. Nihon Kohden had a return on equity of 6.80% and a net margin of 5.77%.

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

Featured Articles

Should You Invest $1,000 in Nihon Kohden Right Now?

Before you consider Nihon Kohden, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nihon Kohden wasn't on the list.

While Nihon Kohden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.